Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis - Slideshow (NASDAQ:TVRD) 2026-08-19
· seekingalpha.com
2026-08-19. The following slide deck was published by Tvardi Therapeutics, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...